Regulatory Story
Go to market news section View chart   Print
Company Skyepharma PLC
TIDM SKP
Headline

Director Declaration

Released 08:05 10-Jul-2014
Number 9141L08

RNS Number : 9141L
Skyepharma PLC
10 July 2014
 



Skyepharma PLC ("Company")

 

Director declaration

 

In accordance with Listing Rule 9.6.14, the Company announces that Peter Grant, Chief Executive Officer of Skyepharma PLC, was appointed in June 2014 as a non-executive director of Abzena Limited, which has since become Abzena plc.  Abzena plc has today been listed on the AIM market of the London Stock Exchange.

 

10 July 2014

 

 

For further information, please contact:

 

Skyepharma PLC

John Murphy

Group Counsel and Company Secretary                                   +44 20 7881 0524


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNLLFERDEIAIIS
Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


Director Declaration - RNS